[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-360422-105":59,"doc-detail-360422-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","integrin-beta-4-promotes-colorectal-cancer-progression-by-upregulating-ezrin-and-activating-the-wnt-catenin-signaling-pathway","Integrin beta 4 promotes colorectal cancer progression by upregulating Ezrin and activating the Wnt/β-catenin signaling pathway","","Colorectal cancer (CRC) is a leading cause of cancer-related mortality worldwide, yet the oncogenic mechanism of integrin beta 4 (ITGB4) remains insufficiently defined. This study evaluates ITGB4 function in CRC progression, identifying downstream molecular effectors to support targeted therapy development. ITGB4 was tested in SW480 and HCT116 cells using proliferation, migration, invasion, and apoptosis assays, with in vivo xenografts assessing tumor growth. RNA sequencing and co-immunoprecipitation/co-immunofluorescence, plus pathway analysis, supported an ITGB4→Ezrin→Wnt/β-catenin axis.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/integrin-beta-4-promotes-colorectal-cancer-progression-by-upregulating-ezrin-and-activating-the-wnt-catenin-signaling-pathway/360422/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/integrin-beta-4-promotes-colorectal-cancer-progression-by-upregulating-ezrin-and-activating-the-wnt-catenin-signaling-pathway/360422.png","ImageObject",300,407,{"name":92,"@type":93},"eBook King","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main goal of the study on ITGB4 in colorectal cancer?","Question",{"text":112,"@type":113},"To clarify ITGB4’s functional role in CRC progression and to identify its downstream molecular effectors relevant to targeted therapy.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did the researchers assess the effects of ITGB4 in CRC?",{"text":117,"@type":113},"They used in vitro assays (cell proliferation, colony formation, migration/invasion, and apoptosis after ITGB4 knockdown) and an in vivo xenograft mouse model to evaluate tumor growth.",{"name":119,"@type":110,"acceptedAnswer":120},"Which downstream pathway axis was identified by the study?",{"text":121,"@type":113},"Ezrin (EZR) was identified as a key downstream target, and ITGB4 regulation of EZR led to activation of the Wnt/β-catenin signaling pathway, forming an ITGB4/EZR/Wnt/β-catenin axis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},360422,1790333982,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962088006270,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","INTERNATIONAL JOURNAL OF ONCOLOGY 69: 82, 2026  \nIntegrin beta 4 promotes colorectal cancer progression by upregulating Ezrin and activating the Wnt/β‑catenin signaling pathway  \nJING WANG 1* , YI SI 1* , MINGDA XUAN 1* , SHUANGSHUANG HAN 1 , KUNYI LIU 1 , JIAO JIAO 1 , XIAOYAN MEN 1 , HONGFEI LI 1 , JIA WANG2 , TING LIU 1 and WEIFANG YU 1  \n1Department of Endoscopy Center, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei 050031, P.R. China; 2  \nDepartment of Infectious Diseases, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei 050031, P.R. China  \nReceived December 12, 2025; Accepted May 6, 2026  \nDOI: 10.3892/ijo.2026.5895  \nAbstract. Colorectal cancer (CRC) is a major cause of cancer‑related mortality worldwide. Integrin beta 4 (ITGB4) has been previously identified as being overexpressed in CRC; however, its precise oncogenic mechanism remains unclear. The present study aimed to elucidate the functional role of ITGB4 in CRC progression and identify its downstream molecular effectors to provide new insights for targeted therapy. The biological functions of ITGB4 were investigated in CRC cell lines (SW480 and HCT116) using a series of in vitro assays, including Cell Counting Kit‑8, colony forma‑ tion, Transwell migration and invasion, and flow cytometry for apoptosis following ITGB4 knockdown. An in vivo xenograft mouse model was used to evaluate the effect of ITGB4 on tumor growth. Downstream targets were screened using RNA sequencing (RNA‑seq) and validated by co‑immunoprecipi‑ tation and co‑immunofluorescence. The underlying signaling pathway was investigated by western blotting and functional  \nCorrespondence to: Professor Weifang Yu or Dr Ting Liu, Department of Endoscopy Center, The First Hospital of Hebei Medical University, 89 Donggang Road, Shijiazhuang, Hebei 050031, P.R. China  \nE‑mail: [yuweifang@hebmu.edu.cn](yuweifang@hebmu.edu.cn)  \nE‑mail: [59103696@hebmu.edu.cn](59103696@hebmu.edu.cn)  \n*Contributed equally  \nAbbreviations: CRC, colorectal cancer; ITGB4, integrin beta 4; EZR, ezrin; CCK‑8, Cell Counting Kit‑8; RNA‑seq, RNA sequencing; Co‑IP, co‑immunoprecipitation; Co‑IF, co‑immunofluorescence; DMEM, Dulbecco's Modified Eagle's Medium; FBS, fetal bovine serum; siRNA, small interfering RNA; shRNA, short hairpin RNA; RT‑qPCR, reverse transcription‑quantitative polymerase chain reaction; IHC, immunohistochemistry; DEGs, differentially expressed genes; TCGA, The Cancer Genome Atlas  \nKey words: CRC, ITGB4, EZR, Wnt/β‑catenin signaling, metastasis, prognostic biomarker, therapeutic target  \nrescue experiments. The results demonstrated that knockdown of ITGB4 significantly suppressed CRC cell proliferation, migration and invasion, while promoting apoptosis in vitro. Similarly, silencing ITGB4 markedly inhibited tumor growth in the in vivo xenograft model. RNA‑seq analysis identified Ezrin (EZR) as a key downstream target of ITGB4, and a direct protein‑protein interaction was confirmed between them . Mechanistically, ITGB4 knockdown decreased the expression of EZR at both the mRNA and protein levels . ITGB4 was demonstrated to exert its pro‑tumorigenic effects through the regulation of EZR, which subsequently activated the Wnt/β‑catenin signaling pathway. Interestingly, EZRoverexpression partially restored ITGB4 levels, suggesting a hypothetical positive feedback loop via Wnt/β‑catenin signaling that could amplify this oncogenic axis. Notably, the malignant phenotypes suppressed by ITGB4 silencing were significantly rescued by the overexpression of EZR. In conclusion, the present study identified a novel ITGB4/EZR/Wnt/β‑catenin signaling axis in CRC. ITGB4 promotes CRC progression by modulating EZR expression and subsequently activating the Wnt/β‑catenin pathway. These findings highlight ITGB4 as a potential prognostic biomarker and a promising therapeutic target for CRC.  \nIntroduction  \nMetastasis remains the primary cause of mortality in patients with colorectal cancer (CRC)","cbCaiuxXlteCcRag","https://ap.wps.com/l/cbCaiuxXlteCcRag","pdf",14660621,14,"English","# Introduction\n## Clinical need and metastasis background\n## Rationale for integrin ITGB4 in CRC","[{\"question\":\"What was the main goal of the study on ITGB4 in colorectal cancer?\",\"answer\":\"To clarify ITGB4’s functional role in CRC progression and to identify its downstream molecular effectors relevant to targeted therapy.\"},{\"question\":\"How did the researchers assess the effects of ITGB4 in CRC?\",\"answer\":\"They used in vitro assays (cell proliferation, colony formation, migration/invasion, and apoptosis after ITGB4 knockdown) and an in vivo xenograft mouse model to evaluate tumor growth.\"},{\"question\":\"Which downstream pathway axis was identified by the study?\",\"answer\":\"Ezrin (EZR) was identified as a key downstream target, and ITGB4 regulation of EZR led to activation of the Wnt/β-catenin signaling pathway, forming an ITGB4/EZR/Wnt/β-catenin axis.\"}]","Integrin beta 4 promotes colorectal cancer progression by upregulating Ezrin and activating the Wnt/β-catenin signaling pathway | PDF",1790140039,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/16988a84f7975e1667fc4978ca29bbb0.webp",983,1357,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6b08a2e84b07ecbaa22554ed24966732.webp",982,1356,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/82d3f6e82575ae5174f17925a0546e0c.webp",981,1354,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9204bc61b08f960028e2dc57bbeec65a.webp",980,1353]